glp-1 news today october 2025 Who Gets the Shot? Access by State Oprah joins wave of celebrities
Description
Our commitment to safe, responsible GLP-1 care
Find out if Aetna covers Mounjaro or other GLP-1 weight loss injections
The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.
Lighter passengers meant less weight on planes American, Delta, Southwest and United are collectively projected to save up to $580M annually
Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.
Yes GLP3 is the informal name for retatrutide, a triple agonist of GLP-1, GIP, and glucagon receptors.
